We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

146 hedge funds and large institutions have $156M invested in Vaxart in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 41 increasing their positions, 43 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $4.45M | Put options by funds: $1.67M

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

0.56% less ownership

Funds ownership: 35.71%35.15% (-0.56%)

5% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 43

1% less funds holding

Funds holding: 148146 (-2)

33% less capital invested

Capital invested by funds: $232M → $156M (-$76.1M)

Holders
146
Holders Change
-2
Holders Change %
-1.35%
% of All Funds
2.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
41
Reduced
43
Closed
19
Calls
$4.45M
Puts
$1.67M
Net Calls
+$2.78M
Net Calls Change
-$59K
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$44.4M -$4.44M -1,189,024 -9%
BlackRock
2
BlackRock
New York
$32.1M +$2.77M +741,604 +9%
Vanguard Group
3
Vanguard Group
Pennsylvania
$23.3M +$2.13M +570,707 +9%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$7.79M -$30.7K -8,219 -0.4%
Morgan Stanley
5
Morgan Stanley
New York
$4.08M -$326K -87,322 -7%
Northern Trust
6
Northern Trust
Illinois
$4.07M -$129K -34,468 -3%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$3.64M -$2.06M -552,255 -35%
Charles Schwab
8
Charles Schwab
California
$3.1M -$78.6K -21,044 -2%
Citadel Advisors
9
Citadel Advisors
Florida
$2.95M +$2.65M +710,626 +538%
Goldman Sachs
10
Goldman Sachs
New York
$2.07M +$586K +156,874 +36%
Citigroup
11
Citigroup
New York
$1.92M +$1.44M +385,738 +238%
Rafferty Asset Management
12
Rafferty Asset Management
New York
$1.88M -$1.71M -459,035 -46%
N
13
Nuveen
North Carolina
$1.81M +$570K +152,663 +42%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$1.48M -$22.4K -5,998 -1%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$1.37M -$1.11M -296,504 -43%
Swiss National Bank
16
Swiss National Bank
Switzerland
$1.04M
IWM
17
IHT Wealth Management
Illinois
$909K +$3.94K +1,055 +0.4%
Mariner
18
Mariner
Kansas
$846K -$34.3K -9,180 -4%
Bank of America
19
Bank of America
North Carolina
$833K -$1.47M -394,009 -62%
RJFSA
20
Raymond James Financial Services Advisors
Florida
$833K -$5.69K -1,524 -0.6%
RhumbLine Advisers
21
RhumbLine Advisers
Massachusetts
$620K +$181K +48,327 +38%
LPL Financial
22
LPL Financial
California
$595K +$74.5K +19,935 +13%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$572K +$316K +84,700 +108%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$557K -$2.96K -791 -0.5%
SG Americas Securities
25
SG Americas Securities
New York
$544K +$581K +155,494 New

VXRT Hedge Fund Activity: Q2 2022 in Review

146 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2022, worth a combined $156M — down 33% from $232M a quarter earlier.

Fund positioning in VXRT was balanced in Q2 2022: 19 funds opened new positions, 19 closed out, 41 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock, adding an estimated $2.77M. The largest seller was State Street, cutting an estimated $4.44M.

  • 146 institutional investors held Vaxart (VXRT) as of Q2 2022, down from 148 in Q1 2022.
  • Funds reported $156M of Vaxart stock for Q2 2022, down 33% quarter-over-quarter.
  • 19 funds opened new Vaxart positions in Q2 2022 and 19 closed out, a net change of 0 holders.
  • The largest Vaxart buyer in Q2 2022 was BlackRock, an estimated $2.77M added.
  • The largest Vaxart seller in Q2 2022 was State Street, an estimated $4.44M sold.

Based on aggregated 13F filings for Q2 2022.